What is an inspection response in GMP?

Short answer

A GMP inspection response is the organisation's formal reply to deficiencies or observations raised by an inspector. It should state what will be corrected, address the wider systemic issue, set realistic completion dates and explain any interim controls needed to protect patients while longer-term work continues. The response must be accurate, approved and supported by a controlled remediation plan.

What should an inspection response achieve?

The response should give the inspector confidence that the organisation understands the finding, has assessed its significance and can restore reliable control. It is not simply an explanation of why the event happened or a list of documents that will be updated.

A strong response distinguishes immediate correction from sustainable corrective and preventive action. It also makes clear who owns each commitment, how progress will be governed and how effectiveness will be demonstrated.

What should the initial response include?

a direct response beneath each deficiency or observation;

a concise statement of the issue and its potential patient, product, data and compliance impact;

immediate corrections and interim risk controls already implemented or planned;

the investigation and root-cause approach, including systemic scope;

specific actions, accountable owners and realistic completion dates;

how similar products, processes, systems or sites have been considered; and

the route for Quality approval, governance and effectiveness verification.

Why must the response consider the wider system?

MHRA guidance asks organisations to think beyond the single example cited. A local correction may close the visible gap while leaving the same weakness elsewhere. The response should therefore explain how the broader system was reviewed and whether related examples were found.

Where no further examples are identified, the method and scope of that review should still be described. This helps show that the conclusion is evidence-based rather than assumed.

When are interim controls needed?

If the permanent solution will take time and operations continue, interim measures should control the immediate risk. Examples may include enhanced Quality review, additional monitoring, restricted activity, batch-specific checks, temporary procedural controls or management escalation.

Interim controls should be proportionate, documented and reviewed until the permanent action is implemented and effective. They should not become an unmanaged substitute for timely remediation.

How should root cause and CAPA be presented?

Do not overstate certainty before an investigation is complete. The response can describe the planned methodology, scope and decision points, then commit to the resulting actions. CAPA should address supported causes and system weaknesses, not merely repeat the wording of the finding.

Each action should have an objective completion criterion. Effectiveness checks should test whether the corrected process performs reliably during routine use, not only whether a document, training record or purchase order exists.

How should commitments and dates be controlled?

Commitments should be specific enough to govern. Avoid vague promises to review, improve or retrain without defining the output, owner and date. Timelines should reflect risk, complexity, dependencies and available resources.

If a committed date cannot be met, the inspector should be told before it expires. The organisation should explain the reason, revised date, current risk position and any strengthened interim control. Previous response text and commitments should remain traceable.

What evidence should be retained or submitted?

The site should maintain a controlled evidence file covering impact assessment, investigation, decisions, CAPA, change control, approvals, implementation and effectiveness. For an MHRA post-inspection response, however, evidence should not be added indiscriminately when it has not been requested. The response should stay concise and relevant while ensuring supporting records are ready for review.

Common weaknesses

The response disputes wording without first controlling the underlying risk.

Actions correct only the cited example and ignore systemic scope.

Timelines are optimistic, vague or unsupported by resources and dependencies.

Root cause is declared too early or reduced to operator error.

CAPA completion is confused with demonstrated effectiveness.

Changes to commitments are made without controlled communication.

Questions to ask internally

Does every deficiency have a direct, concise and owned response?

Have patient, product, data and wider-system impacts been assessed?

Are interim controls adequate for the risk while work remains open?

Would the evidence demonstrate implementation and sustained control?

How W2 Cleanroom Consulting can help

W2 Cleanroom Consulting can independently review draft inspection responses, challenge systemic scope, assess remediation plans, test CAPA logic and support governance or reinspection readiness where GMP connects with cleanrooms, aseptic services, validation and contamination control. The client remains responsible for regulatory correspondence, Quality decisions and formal approvals.

Related GxP knowledge

What happens after a bad GMP inspection?

What is GMP remediation?

What is root cause analysis in GMP?

What is CAPA in GMP?

GMP inspection remediation support

Need an independent review of a GMP inspection response? Contact W2 Cleanroom Consulting.

Prepared and reviewed by: W2 Cleanroom Consulting GMP team. Last reviewed: 24 July 2026.